首页> Journal of medicinal chemistry> Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.

Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.

导出原文传递

翻译打印收藏纠错

第一作者： Matthew,Volgraf

第一单位： Pharmaron-Beijing Co. Ltd. , 6 Taihe Road, BDA, Beijing 100176, PR China.

作者： Matthew,Volgraf ^[1] ; Benjamin D,Sellers ^[1] ; Yu,Jiang ^[1] ; Guosheng,Wu ^[1] ; Cuong Q,Ly ^[1] ; Elisia,Villemure ^[1] ; Richard M,Pastor ^[1] ; Po-wai,Yuen ^[1] ; Aijun,Lu ^[1] ; Xifeng,Luo ^[2] ; Mingcui,Liu ^[2] ; Shun,Zhang ; Liang,Sun ; Yuhong,Fu ; Patrick J,Lupardus ; Heidi J A,Wallweber ; Bianca M,Liederer ; Gauri,Deshmukh ; Emile,Plise ; Suzanne,Tay ; Paul,Reynen ; James,Herrington ; Amy,Gustafson ; Yichin,Liu ; Akim,Dirksen ; Matthias G A,Dietz ; Yanzhou,Liu ; Tzu-Ming,Wang ; Jesse E,Hanson ; David,Hackos ; Kimberly,Scearce-Levie ; Jacob B,Schwarz

作者单位： Pharmaron-Beijing Co. Ltd. , 6 Taihe Road, BDA, Beijing 100176, PR China. ^[1] Ion Channels Group, Evotec AG ; Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany. ^[2]